These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8098354)

  • 1. Synaptic neurochemistry of human striatum during development: changes in sudden infant death syndrome.
    Kalaria RN; Fiedler C; Hunsaker JC; Sparks DL
    J Neurochem; 1993 Jun; 60(6):2098-105. PubMed ID: 8098354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden infant death syndrome: altered aminergic-cholinergic synaptic markers in hypothalamus.
    Sparks DL; Hunsaker JC
    J Child Neurol; 1991 Oct; 6(4):335-9. PubMed ID: 1719064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and serotonergic neurotransmitters in bone marrow transplant patients.
    Davis DG; Sparks DL
    J Neurol Sci; 1995 May; 130(1):95-103. PubMed ID: 7544403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choline-acetyltransferase (ChAT) and acetylcholinesterase (AChE) in the human infant dorsal motor nucleus of the Vagus (DMNV), and alterations according to sudden infant death syndrome (SIDS) category.
    Joda M; Waters KA; Machaalani R
    Neurobiol Dis; 2023 Nov; 188():106319. PubMed ID: 37813167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines, and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific cortico-striatal transmitter.
    Hassler R; Haug P; Nitsch C; Kim JS; Paik K
    J Neurochem; 1982 Apr; 38(4):1087-98. PubMed ID: 6121000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triple risk hypotheses in sudden infant death syndrome.
    Guntheroth WG; Spiers PS
    Pediatrics; 2002 Nov; 110(5):e64. PubMed ID: 12415070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid.
    McGeer EG; McGeer PL
    Neurochem Res; 1978 Aug; 3(4):501-17. PubMed ID: 34114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in choline acetyltransferase immunoreactivity but not muscarinic-m2 receptor immunoreactivity in the brainstem of SIDS infants.
    Mallard C; Tolcos M; Leditschke J; Campbell P; Rees S
    J Neuropathol Exp Neurol; 1999 Mar; 58(3):255-64. PubMed ID: 10197817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of putative transmitters in the hippocampal formation: with a note on the connections to septum and hypothalamus.
    Storm-Mathisen J
    Ciba Found Symp; 1977; (58):49-86. PubMed ID: 32019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants.
    Heininger U; Kleemann WJ; Cherry JD;
    Pediatrics; 2004 Jul; 114(1):e9-15. PubMed ID: 15231967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal lesions with kainic acid: neurochemical characteristics.
    Schwarcz R; Coyle JT
    Brain Res; 1977 May; 127(2):235-49. PubMed ID: 16686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental neurotransmitter pathology in the brainstem of sudden infant death syndrome: a review and sleep position.
    Ozawa Y; Takashima S
    Forensic Sci Int; 2002 Sep; 130 Suppl():S53-9. PubMed ID: 12350301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in brain neurotransmission.
    Petkov VD; Petkov VV; Stancheva SL
    Gerontology; 1988; 34(1-2):14-21. PubMed ID: 2898418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intrastriatal kainic acid injection on [3H]dopamine metabolism in rat striatal slices: evidence for postsynaptic glial cell metabolism by both the type A and B forms of monoamine oxidase.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1983 May; 40(5):1340-8. PubMed ID: 6131940
    [No Abstract]   [Full Text] [Related]  

  • 17. Down's syndrome individuals begin life with normal levels of brain cholinergic markers.
    Kish S; Karlinsky H; Becker L; Gilbert J; Rebbetoy M; Chang LJ; DiStefano L; Hornykiewicz O
    J Neurochem; 1989 Apr; 52(4):1183-7. PubMed ID: 2522539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature and mechanisms of cholinergic-monoaminergic interactions in the brain.
    Butcher LL
    Life Sci; 1977 Nov; 21(9):1207-26. PubMed ID: 337018
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1994 Apr; 643(1-2):276-81. PubMed ID: 7518327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.